Also, for the group of IDH-mutant astrocytomas a reworked grading system was proposed, acknowledging homozygous loss of CDKN2A as a main factor of unfavorable prognosis [3]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).